Făgărășanu et al. (2022) emphasized the prognostic implications of RAF1 variants, particularly in a patient with hypertrophic cardiomyopathy and arrhythmic risk [44]. This evidence concerns the gene RAF1 and hypertrophic cardiomyopathy.